533 related articles for article (PubMed ID: 9398000)
21. Bile acid profiles by capillary electrophoresis in intrahepatic cholestasis of pregnancy.
Castaño G; Lucangioli S; Sookoian S; Mesquida M; Lemberg A; Di Scala M; Franchi P; Carducci C; Tripodi V
Clin Sci (Lond); 2006 Apr; 110(4):459-65. PubMed ID: 16356162
[TBL] [Abstract][Full Text] [Related]
22. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.
Brites D; Rodrigues CM; Oliveira N; Cardoso M; Graça LM
J Hepatol; 1998 Jan; 28(1):91-8. PubMed ID: 9537870
[TBL] [Abstract][Full Text] [Related]
23. Corticotropin-releasing hormone expression in patients with intrahepatic cholestasis of pregnancy after ursodeoxycholic acid treatment: an initial experience.
Zhou F; Zhang L; He MM; Liu ZF; Gao BX; Wang XD
Curr Med Res Opin; 2014 Aug; 30(8):1529-35. PubMed ID: 24665980
[TBL] [Abstract][Full Text] [Related]
24. New Insights on Intrahepatic Cholestasis of Pregnancy.
Floreani A; Gervasi MT
Clin Liver Dis; 2016 Feb; 20(1):177-89. PubMed ID: 26593298
[TBL] [Abstract][Full Text] [Related]
25. Fetal death in a patient with intrahepatic cholestasis of pregnancy.
Sentilhes L; Verspyck E; Pia P; Marpeau L
Obstet Gynecol; 2006 Feb; 107(2 Pt 2):458-60. PubMed ID: 16449148
[TBL] [Abstract][Full Text] [Related]
26. Sex hormones and bile acids in intrahepatic cholestasis of pregnancy.
Reyes H
Hepatology; 2008 Feb; 47(2):376-9. PubMed ID: 18220280
[No Abstract] [Full Text] [Related]
27. Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis.
Lindor KD; Lacerda MA; Jorgensen RA; DeSotel CK; Batta AK; Salen G; Dickson ER; Rossi SS; Hofmann AF
Am J Gastroenterol; 1998 Sep; 93(9):1498-504. PubMed ID: 9732932
[TBL] [Abstract][Full Text] [Related]
28. The reversed feto-maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acid.
Geenes V; Lövgren-Sandblom A; Benthin L; Lawrance D; Chambers J; Gurung V; Thornton J; Chappell L; Khan E; Dixon P; Marschall HU; Williamson C
PLoS One; 2014; 9(1):e83828. PubMed ID: 24421907
[TBL] [Abstract][Full Text] [Related]
29. S-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial.
Floreani A; Paternoster D; Melis A; Grella PV
Eur J Obstet Gynecol Reprod Biol; 1996 Aug; 67(2):109-13. PubMed ID: 8841797
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
Kong X; Kong Y; Zhang F; Wang T; Yan J
Medicine (Baltimore); 2016 Oct; 95(40):e4949. PubMed ID: 27749550
[TBL] [Abstract][Full Text] [Related]
31. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
Chappell LC; Chambers J; Dixon PH; Dorling J; Hunter R; Bell JL; Bowler U; Hardy P; Juszczak E; Linsell L; Rounding C; Smith A; Williamson C; Thornton JG
Trials; 2018 Nov; 19(1):657. PubMed ID: 30482254
[TBL] [Abstract][Full Text] [Related]
32. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
Grymowicz M; Czajkowski K; Smolarczyk R
Scand J Gastroenterol; 2016 Jan; 51(1):78-85. PubMed ID: 26152830
[TBL] [Abstract][Full Text] [Related]
33. Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis.
Gümüş Güler B; Özler S
Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):271-276. PubMed ID: 31919038
[TBL] [Abstract][Full Text] [Related]
34. Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy.
Geenes V; Chambers J; Khurana R; Shemer EW; Sia W; Mandair D; Elias E; Marschall HU; Hague W; Williamson C
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():59-63. PubMed ID: 25864112
[TBL] [Abstract][Full Text] [Related]
35. Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy.
Reyes H; Sjövall J
Ann Med; 2000 Mar; 32(2):94-106. PubMed ID: 10766400
[TBL] [Abstract][Full Text] [Related]
36. Intrahepatic cholestasis of pregnancy: a French prospective study.
Bacq Y; Sapey T; Bréchot MC; Pierre F; Fignon A; Dubois F
Hepatology; 1997 Aug; 26(2):358-64. PubMed ID: 9252146
[TBL] [Abstract][Full Text] [Related]
37. Profiles of bile acids and progesterone metabolites in the urine and serum of women with intrahepatic cholestasis of pregnancy.
Meng LJ; Reyes H; Palma J; Hernandez I; Ribalta J; Sjövall J
J Hepatol; 1997 Aug; 27(2):346-57. PubMed ID: 9288610
[TBL] [Abstract][Full Text] [Related]
38. Effects of ursodeoxycholic acid on synthesis of cholesterol and bile acids in healthy subjects.
Sauter GH; Thiessen K; Parhofer KG; Jüngst C; Fischer S; Jüngst D
Digestion; 2004; 70(2):79-83. PubMed ID: 15375335
[TBL] [Abstract][Full Text] [Related]
39. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: a randomized controlled trial.
Joutsiniemi T; Timonen S; Leino R; Palo P; Ekblad U
Arch Gynecol Obstet; 2014 Mar; 289(3):541-7. PubMed ID: 23978872
[TBL] [Abstract][Full Text] [Related]
40. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
